SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2011 / Cilt: 38 - Sayı: 1

MicroRNAs and cancer

MikroRNA’lar ve kanser

FARUK SAYDAM
İRFAN DEĞİRMENCİ
Hasan Veysi GÜNEŞ
Pages
113–120
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, miRNA biogenesis and their roles in cancer progression are described and studies setting out the relationship between miRNAs and cancer are reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:MicroRNAs (MiRNAs) are highly conserved, non-protein-coding, approximately 18-24 nucleotides, small RNA molecules.
📊
Key Findings & Data:These non-protein-coding RNAs bind target mRNAs which are complementary with their squences and post-transcriptionally regulate gene expression through translation repression or mRNA degradation.
💡
Conclusion & Impact:In this review, miRNA biogenesis and their roles in cancer progression are described and studies setting out the relationship between miRNAs and cancer are reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

MicroRNAs (MiRNAs) are highly conserved, non-protein-coding, approximately 18-24 nucleotides, small RNA molecules. These non-protein-coding RNAs bind target mRNAs which are complementary with their squences and post-transcriptionally regulate gene expression through translation repression or mRNA degradation. Using this pathway, miRNAs play important roles in homeostatic process including cell proliferation, differentiation and cell death. Recent studies based on gene expression have revealed that miRNA expressions are deregulated in cancer cells which have uncontrolled grow. According to character of target mRNA, miRNAs act like tumor supressor or oncogene in cancer initiation and progression. In this review, miRNA biogenesis and their roles in cancer progression are described and studies setting out the relationship between miRNAs and cancer are reviewed.

Özet

MikroRNA(miRNA)’lar, yüksek seviyede korunan DNA bölgelerinden kodlanan fakat proteine translasyonu gerçekleşmeyen, yaklaşık 18-24 nükleotid uzunluğunda, küçük RNA molekülleridir. Bu protein kodlamayan RNA molekülleri kendi nükleotid dizilerinin tamamlayıcısı olan hedef mRNA’lara bağlanıp translasyonel baskılama veya mRNA yıkımı ile transkripsiyon sonrası gen ekspresyonunun düzenlenmesini gerçekleştirirler. miRNA’lar bu yolağı kullanarak hücre proliferasyonu, hücre farklılaşması ve hücre ölümü gibi homeostatik süreçlerde önemli roller oynamaktadır. Yakın zamanda yapılan gen ekspresyon çalışmaları, kontrolsüz hücre bölünmesinin gerçekleştiği kanser hücrelerinde değişikliğe uğramış miRNA ekspresyonlarını gözler önüne sermiştir. Kanserin başlamasında ve ilerlemesinde, miRNA’lar hedefledikleri genin karakterine göre tümör süpresörler veya onkogenler gibi fonksiyon göstermektedirler. Bu derlemede miRNA oluşumu ve miRNA’ların kanser gelişimindeki rolleri anlatılmış olup, miRNA’ların kanser ile olan ilişkisini ortaya koyan çalışmalar gözden geçirilmiştir.

🔖

Cite This Article

SAYDAM, F., DEĞİRMENCİ, İ., GÜNEŞ, H. V. (2011). MicroRNAs and cancer. Dicle Tıp Dergisi, Cilt: 38 - Sayı: 1, 113–120. https://ajindex.com/articles/349851

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Wijnhoven BP, Michael MZ, Watson DI. MicroRNAs and cancer. Br J Surg 2007; 94: 23–30
  2. Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 2009;28:369–378
  3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843–854
  4. Ruvkun G. Molecular biology. Glimpses of a tiny RNA world. Science 2001; 294: 797–799
  5. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403, 901–906
  6. Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000;408(6808):86–89
  7. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001;294:853–858
  8. Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer. Cancer Sci 2010; 101: 2309-2315
  9. Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415-419
  10. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer.Nat Rev Cancer.2006;6:259-269
  11. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303:95-98
  12. Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W. Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 2002; 21:5875-5885
  13. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001;409:363-366
  14. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005;123:631-640
  15. Sun W, Li YSJ, Huang HD, Shyy JYJ, Chien S. microRNA: A Master Regulator of Cellular Processes for Bioengineering Systems. Annu Rev Biomed Eng 2010;12:1-27 16. Pillai RS. MicroRNA function: multiple mechanisms fora tiny RNA? RNA 2005;11:1753–1761
  16. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99):15524-15529
  17. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;10